Akero Therapeutics Inc

NAS:AKRO (USA)  
$ 23.98 -0.64 (-2.6%) 10:08 PM EST
At Loss
P/B:
1.96
Enterprise V:
$ 790.77M
Volume:
559.13K
Avg Vol (2M):
748.90K
Trade In:
Volume:
559.13K
At Loss
Avg Vol (2M):
748.90K

Business Description

Description
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
Name Current Vs Industry Vs History
Cash-To-Debt 24.97
Equity-to-Asset 0.93
Debt-to-Equity 0.04
Debt-to-EBITDA -0.21
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 72.74
9-Day RSI 70.55
14-Day RSI 65.1
6-1 Month Momentum % -9.05
12-1 Month Momentum % -63.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 30.12
Quick Ratio 30.12
Cash Ratio 29.86

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -17.1
Shareholder Yield % -42.51

Financials (Next Earnings Date:2024-08-09 Est.)

AKRO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AKRO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Akero Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.23
Beta -0.88
Volatility % 107.1
14-Day RSI 65.1
14-Day ATR ($) 1.461866
20-Day SMA ($) 20.809
12-1 Month Momentum % -63.2
52-Week Range ($) 11.25 - 56.66
Shares Outstanding (Mil) 69.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Akero Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Akero Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Akero Therapeutics Inc Frequently Asked Questions

What is Akero Therapeutics Inc(AKRO)'s stock price today?
The current price of AKRO is $23.98. The 52 week high of AKRO is $56.66 and 52 week low is $11.25.
When is next earnings date of Akero Therapeutics Inc(AKRO)?
The next earnings date of Akero Therapeutics Inc(AKRO) is 2024-08-09 Est..
Does Akero Therapeutics Inc(AKRO) pay dividends? If so, how much?
Akero Therapeutics Inc(AKRO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1